Company Filing History:
4 out of 417 
2 out of 257 
1 out of 20 Years Active: 2015-2025
Title: Ikumi Kuriwaki: Innovator in Pharmaceutical Chemistry
Introduction
Ikumi Kuriwaki is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of six patents to her name, Kuriwaki's work is recognized for its potential impact on treating various diseases.
Latest Patents
Among her latest patents is the invention of bicyclic 1,4-diazepanones and their therapeutic uses. This patent provides compounds of a specific formula, including stereoisomers and pharmaceutically acceptable salts. The invention outlines methods for using these compounds to treat diseases and conditions that respond to the modulation of skeletal sarcomere contractility. This innovative approach highlights Kuriwaki's commitment to advancing medical science through her research.
Career Highlights
Kuriwaki has worked with notable companies in the pharmaceutical industry, including Astellas Pharma GmbH and Cytokinetics, Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Throughout her career, Kuriwaki has collaborated with esteemed colleagues such as Hiroyuki Hisamichi and Bradley Paul Morgan. These partnerships have fostered an environment of innovation and have led to the successful development of her patented compounds.
Conclusion
Ikumi Kuriwaki's contributions to pharmaceutical chemistry exemplify her dedication to innovation and research. Her patents and collaborations reflect her significant role in advancing therapeutic solutions for various medical conditions.